Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
McKesson
Moodys
Julphar
Fuji
Argus Health
Johnson and Johnson
Colorcon
Deloitte

Generated: July 19, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: DEFERASIROX

« Back to Dashboard

DEFERASIROX

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Novartis Pharms Corp JADENU SPRINKLE deferasirox GRANULE;ORAL 207968 NDA Novartis Pharmaceuticals Corporation N 0078-0713-15
Novartis Pharms Corp JADENU SPRINKLE deferasirox GRANULE;ORAL 207968 NDA Novartis Pharmaceuticals Corporation N 0078-0720-15
Novartis Pharms Corp JADENU SPRINKLE deferasirox GRANULE;ORAL 207968 NDA Novartis Pharmaceuticals Corporation N 0078-0727-15
Novartis EXJADE deferasirox TABLET, FOR SUSPENSION;ORAL 021882 NDA Novartis Pharmaceuticals Corporation N 0078-0468-15
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
McKinsey
Deloitte
Express Scripts
Covington
Boehringer Ingelheim
Argus Health
Chinese Patent Office
Accenture